Medical device-make Stryker Corporation — which resolved FCPA cases in 2013 and 2018 — said Tuesday in an SEC filing that it is “currently investigating whether certain business activities in a foreign country violated provisions of the Foreign Corrupt Practices Act.”
Stryker, based in Kalamazoo, Michigan, said it has “engaged outside counsel to conduct” the new investigation.
Source: Stryker discloses new FCPA investigation after two prior enforcement actions | The FCPA Blog
